Enrolling by Invitation
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT05635747
- Conditions
- Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +8 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Boston Children's Hospital Boston, Massachusetts, United States